The Journal of Critical Care Medicine (Nov 2022)

Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes

  • Al-Dorzi Hasan M.,
  • Alqirnas Muhannad Q.,
  • Hegazy Mohamed M.,
  • Alghamdi Abdullah S.,
  • Alotaibi Mohammed T.,
  • Albogami Mohammed T.,
  • Alhafi Mohammed M.,
  • Alwadani Salem,
  • Elsharkawi Ashraf,
  • Arabi Yaseen M.

DOI
https://doi.org/10.2478/jccm-2022-0023
Journal volume & issue
Vol. 8, no. 4
pp. 249 – 258

Abstract

Read online

COVID-19 is characterized by a procoagulant state that increases the risk of venous and arterial thrombosis. The dose of anticoagulants in patients with severe COVID-19 pneumonia without suspected or confirmed thrombosis has been debated.

Keywords